what is the most performance mid cap stock between january 1 2017 and march 30 2017

TG Therapeutics (TGTX) had the highest return between January 1, 2017 and March 30, 2017 by a mid-cap US stock, returning 138.5%.

ASSET DATE % RETURN
TG Therapeutics (TGTX)
1/1/2017 - 3/30/2017
138.54%
Star Bulk Carriers (SBLK)
1/1/2017 - 3/30/2017
129.01%
Quantum Computing  (QUBT)
1/1/2017 - 3/30/2017
100%
Catalyst Pharmaceuticals (CPRX)
1/1/2017 - 3/30/2017
91.35%
Chemours (CC)
1/1/2017 - 3/30/2017
76.9%
Mesoblast (MESO)
1/1/2017 - 3/30/2017
68.41%
National Beverage (FIZZ)
1/1/2017 - 3/30/2017
64.49%
Light & Wonder (LNW)
1/1/2017 - 3/30/2017
61.4%
Option Care Health (OPCH)
1/1/2017 - 3/30/2017
58.72%
Corcept Therapeutics (CORT)
1/1/2017 - 3/30/2017
56.1%
MakeMyTrip (MMYT)
1/1/2017 - 3/30/2017
51.56%
Universal Display (OLED)
1/1/2017 - 3/30/2017
51.1%
Transportadora de Gas del Sur SA ADR (TGS)
1/1/2017 - 3/30/2017
50.11%
Pampa Energia SA ADR (PAM)
1/1/2017 - 3/30/2017
48.65%
Glaukos (GKOS)
1/1/2017 - 3/30/2017
47.24%
Extreme Networks (EXTR)
1/1/2017 - 3/30/2017
46.14%
RH (RH)
1/1/2017 - 3/30/2017
45.94%
Wix (WIX)
1/1/2017 - 3/30/2017
45.52%
Energy of Minas Gerais Co DRC (CIG.C)
1/1/2017 - 3/30/2017
45.31%
HUTCHMED DRC (HCM)
1/1/2017 - 3/30/2017
44.86%
TAL Education (TAL)
1/1/2017 - 3/30/2017
44.7%
Century Aluminum (CENX)
1/1/2017 - 3/30/2017
44.67%
Lantheus (LNTH)
1/1/2017 - 3/30/2017
43.35%
Amicus Therapeutics (FOLD)
1/1/2017 - 3/30/2017
41.93%
Nova (NVMI)
1/1/2017 - 3/30/2017
41.17%
Mid-cap stocks are treated as having a market cap between $2B and $10B.